First Double Heart Valve Replacement without Open Heart Surgery in India

Jaipur/New Delhi: A 55-year-old Canadian patient, who is originally from Chandigarh, underwent successful two heart valve replacements without open heart surgery after a team of doctors at Eternal Hospital in Jaipur have successfully performed TAVI and TMVR.

The patient was suffering from several heart problems — severe aortic stenosis, severe mitral stenosis and severe mitral annular calcification. The patient was admitted to the hospital with the condition of heart failure, a history of shortness-of-breath, difficulty in walking and carrying out the daily activities. Traditionally such patients are treated with open heart surgery. However, due to his calcification in aorta and chest wall, he was deemed high risk for open heart surgery by more than three surgeons from all across the country.

The team of doctors was led by interventional cardiologist and structural heart disease specialist Dr.Ravinder Singh Rao, Director – TAVI and Structural Heart Disease Eternal Hospital, Jaipur. The patient was suffering from several heart problems — severe aortic stenosis, severe mitral stenosis and severe mitral annular calcification. The procedure of the treatment was the replacement of the aortic valve using TAVI,and a new valve was placed inside the old valve. The new valve started functioning immediately and had no complications. Substituting the mitral valve in calcified stenosis was one of the biggest challenges. The new valve was placed by going from the femoral vein (found in the leg) under fluoroscopic andecho visualisation.

This is the first ever successful TMVR in MAC (Mitral Annular Calcification) in the country and the first case of native transcatheter double valve replacement which resulted in “no complication” and “both the valves started functioning immediately”.

Dr. Rao who specializes in TAVI and TMVR from Mount Sinai, New York and Washington University School of Medicines, St Louis, US decided to perform TAVI and TMVR in MAC (Mitral Annular Calcification) in the same sitting.

“The aortic valve was replaced using TAVI, and a new valve was placed inside the old valve. The new valve started functioning immediately and had no complications. Substituting the mitral valve in calcified stenosis was one of the biggest challenges. The new valve was placed by going from the femoral vein (found in the leg) under fluoroscopic and echo visualisation. The valve was then deployed under rapid pacing following which both the valves began to function. Both the valves started functioning immediately and had no complication,” Said Dr. Ravinder Singh Rao, Director – TAVI and Structural Heart Disease Eternal Hospital, Jaipur.

Related Posts

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

AiMeD welcomes the move long overdue to boost India’s Regulatory Framework New Delhi: 21 Drug Inspectors have been promoted to Assistant Drugs Controllers (India) under CDSCO. It was long unmet…

Yashoda Medicity lifts Benchmark in Critical Care to New High

With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Brain organoid maturation is driven by a lifelike developmental clock: Study

Brain organoid maturation is driven by a lifelike developmental clock: Study

Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000